Scott & Selber Inc’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-4,529
Closed -$2.22M 115
2021
Q1
$2.22M Buy
4,529
+20
+0.4% +$10K 0.91% 32
2020
Q4
$2.25M Sell
4,509
-5,232
-54% -$2.34M 0.96% 33
2020
Q3
$3.83M Buy
9,741
+47
+0.5% +$17.4K 1.71% 14
2020
Q2
$3.2M Sell
9,694
-126
-1% -$36.5K 1.58% 17
2020
Q1
$2.38M Buy
9,820
+78
+0.8% +$20.4K 1.48% 22
2019
Q4
$2.54M Sell
9,742
-38
-0.4% -$10K 1.2% 37
2019
Q3
$2.66M Buy
9,780
+51
+0.5% +$14.2K 1.36% 32
2019
Q2
$2.68M Buy
9,729
+683
+8% +$168K 1.35% 29
2019
Q1
$2.02M Sell
9,046
-7,606
-46% -$1.57M 1.06% 43
2018
Q4
$3.1M Sell
16,652
-1,256
-7% -$258K 1.89% 19
2018
Q3
$4.47M Buy
17,908
+4
+0% +$971 2.2% 10
2018
Q2
$3.9M Buy
+17,904
New +$3.69M 2.09% 14

Other funds holding IDXX

Scott & Selber Inc's IDXX Position: Q2 2021 in Review

Scott & Selber Inc sold out of Idexx Laboratories (IDXX) in Q2 2021, closing a stake of 4,529 shares — an estimated $2.22M sold.

Scott & Selber Inc first reported a position in IDXX in Q2 2018 and held it in 12 quarters. The position peaked at $4.47M in Q3 2018. 1,034 funds tracked by Wall St. Rank hold IDXX as of Q2 2021.

  • Scott & Selber Inc reported no remaining Idexx Laboratories position as of Q2 2021 after selling out during the quarter.
  • Scott & Selber Inc sold 4,529 Idexx Laboratories shares in Q2 2021, an estimated $2.22M.
  • Scott & Selber Inc first reported a position in Idexx Laboratories in Q2 2018 and held it in 12 quarters.
  • Scott & Selber Inc's Idexx Laboratories position peaked at $4.47M in Q3 2018.
  • 1,034 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2021.

Based on Scott & Selber Inc's 13F filing for Q2 2021, filed 10 Aug 2021.